相关实验视频
Updated: Sep 17, 2025

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.1K
用化疗治疗的乳腺癌患者的长期体重变化:一项超过13年的纵向研究
Mathilde His1,2, Iris Baggio3, Sylvie Chabaud4
1Prevention Cancer Environment Department, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France. Mathilde.his@lyon.unicancer.fr.
Breast cancer research : BCR
|July 2, 2025
概括
接受化疗的乳腺癌患者经常增加体重,特别是在第一年. 这种体重增加持续了很长一段时间,这凸显了需要早期干预策略来管理化疗引起的体重变化.
科学领域:
- 在瘤学瘤学.
- 临床营养学 临床营养学
- 癌症的生存率 癌症的生存率
背景情况:
- 体重增加是乳腺癌患者化疗的常见副作用.
- 这些患者的长期体重变化及其原因尚不清楚.
- 这项研究研究了化学疗法治疗的早期乳腺癌患者在13年的体重变化.
研究的目的:
- 在辅助化疗后,在早期乳腺癌患者中表征长期体重变化.
- 为了确定13年的随访期间体重变化的潜在决定因素.
主要方法:
- 分析了267名早期乳腺癌患者的队列,这些患者接受了辅助化疗.
- 在13年的时间里,从医疗记录和问卷中收集了每年体重数据.
- 混合效应模型被用来分析体重变化和确定影响因素.
主要成果:
- 超过三分之一的患者在化疗的第一年内显著增加体重 (>5%).
- 这种体重增加是统计学上显著的 (平均1.80公斤),持续了长达13年.
- 体重增加主要观察到初始体重指数 (BMI) <25 kg/m2的患者;化疗类型,激素治疗,年龄,更年期状态和体力活动没有显著关联.
结论:
- 乳腺癌患者在化疗的第一年发生显著和持续的体重增加.
- 了解这种体重增加的决定因素至关重要.
- 开发预防早期体重增加的干预措施是改善患者治疗结果的优先事项.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

